Gilead Sciences, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionTIFF INVESTMENT PROGRAM - TIFF Multi-Asset Fund
Latest Disclosed Ownership3,663 shares
Latest Disclosed Value $ 406,116
TIFF INVESTMENT PROGRAM - TIFF Multi-Asset Fund ownership in GILD / Gilead Sciences, Inc.

On August 27, 2025 - TIFF INVESTMENT PROGRAM - TIFF Multi-Asset Fund filed a NPORT-P form disclosing ownership of 3,663 shares of Gilead Sciences, Inc. (US:GILD) valued at $406,117 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 29, 2025 disclosing 3,663 shares of Gilead Sciences, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $473,113 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-27 2025-06-30 NP Gilead Sciences EC US3755581036 3,663 0 0.00 406 -0.98 0.0289
2025-05-29 2025-03-31 NP Gilead Sciences EC US3755581036 3,663 -6,844 -65.14 410 -57.73 0.0321
2025-02-28 2024-12-31 NP Gilead Sciences EC US3755581036 10,507 0 0.00 971 10.23 0.0740
2024-11-29 2024-09-30 NP Gilead Sciences EC US3755581036 10,507 -1,406 -11.80 881 7.71 0.0671
2024-08-27 2024-06-30 NP Gilead Sciences EC US3755581036 11,913 0 0.00 817 -6.31 0.0643
2024-05-28 2024-03-31 NP Gilead Sciences EC US3755581036 11,913 0 0.00 873 -9.64 0.0688
2024-02-27 2023-12-31 NP Gilead Sciences EC US3755581036 11,913 0 0.00 965 8.18 0.0753
2023-11-27 2023-09-30 NP Gilead Sciences EC US3755581036 11,913 0 0.00 893 -2.83 0.0715
2023-08-28 2023-06-30 NP Gilead Sciences EC US3755581036 11,913 0 0.00 918 -7.09 0.0716
2023-05-25 2023-03-31 NP Gilead Sciences EC US3755581036 11,913 -664 -5.28 988 -8.43 0.0751
2023-02-24 2022-12-31 NP Gilead Sciences EC US3755581036 12,577 -18,922 -60.07 1,080 -44.47 0.0852
2022-11-28 2022-09-30 NP Gilead Sciences EC US3755581036 31,499 20,703 191.77 1,943 191.30 0.1603
2022-08-23 2022-06-30 NP Gilead Sciences EC US3755581036 10,796 10,796 667 0.0517
2021-08-19 2021-06-30 NP Gilead Sciences EC US3755581036 0 -6,659 -100.00 0 -100.00
2021-05-25 2021-03-31 NP Gilead Sciences EC US3755581036 6,659 7,200 -1,330.87 430 -1,364.71 0.0268
2021-05-25 2021-03-31 NP Gilead Sciences EC US3755581036 -541 -11,151 -105.10 -35 -105.50 -0.0022
2021-02-05 2020-12-31 NP Gilead Sciences EC US3755581036 10,610 11,151 -2,061.18 618 -2,093.55 0.0395
2021-02-05 2020-12-31 NP Gilead Sciences EC US3755581036 -541 -11,670 -104.86 -32 -104.41 -0.0020
2020-11-25 2020-09-30 NP Gilead Sciences EC US3755581036 11,129 11,670 -2,157.12 703 -1,814.63 0.0486
2020-08-06 2020-06-30 NP Gilead Sciences EC US3755581036 -541 -13,960 -104.03 -42 -103.97 -0.0027
2020-08-06 2020-06-30 NP Gilead Sciences EC US3755581036 13,419 -5,962 -30.76 1,032 -28.73 0.0659
2020-05-27 2020-03-31 NP Gilead Sciences EC US3755581036 19,381 19,922 -3,682.44 1,449 -3,720.00 0.0965
2020-05-27 2020-03-31 NP Gilead Sciences EC US3755581036 -541 -19,922 -102.79 -40 -103.18 -0.0027
2020-02-10 2019-12-31 NP Gilead Sciences EC US3755581036 19,381 19,922 -3,682.44 1,259 -3,697.14 0.0658
2020-02-10 2019-12-31 NP Gilead Sciences EC US3755581036 -541 0 -0.00 -35 2.94 -0.0018
2019-11-26 2019-09-30 NP Gilead Sciences EC US3755581036 -541 -19,922 -102.79 -34 -102.77 -0.0017
2019-11-26 2019-09-30 NP Gilead Sciences 375558103 19,381 19,381 1,228
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.